These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 1456888)

  • 1. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
    Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus.
    Gowda SD; Stein BS; Engleman EG
    J Biol Chem; 1989 May; 264(15):8459-62. PubMed ID: 2785991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphogenesis of recombinant HIV-2 gag core particles.
    Voss G; Kirchhoff F; Nick S; Moosmayer D; Gelderblom H; Hunsmann G
    Virus Res; 1992 Jul; 24(2):197-210. PubMed ID: 1529643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
    McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
    J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
    Dru A; Ludosky MA; Cartaud J; Beaud G
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):383-90. PubMed ID: 7520722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    Spearman P; Wang JJ; Vander Heyden N; Ratner L
    J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells.
    Luo L; Li Y; Kang CY
    Virology; 1990 Dec; 179(2):874-80. PubMed ID: 2238477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
    zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
    J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.
    Mergener K; Fäcke M; Welker R; Brinkmann V; Gelderblom HR; Kräusslich HG
    Virology; 1992 Jan; 186(1):25-39. PubMed ID: 1727601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Karacostas V; Nagashima K; Gonda MA; Moss B
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8964-7. PubMed ID: 2479031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
    Hoshikawa N; Kojima A; Yasuda A; Takayashiki E; Masuko S; Chiba J; Sata T; Kurata T
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus].
    Iordanskiĭ SN; Lideman LF; Chikova AK; Gibadulin RA
    Vopr Virusol; 1997; 42(5):205-8. PubMed ID: 9424843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.
    Shioda T; Shibuta H
    Virology; 1990 Mar; 175(1):139-48. PubMed ID: 1689917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
    Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
    Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L; Li Y; Cannon PM; Kim S; Kang CY
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.